Product Information
IMIPRAMINE PAMOATE 100 MG CAP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $3.3963 per EA under NDC 68180031506. Its NADAC has been published 510 times since Nov 28, 2013.
Strength
100 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180031506
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMIPRAMINE PAMOATEApproval Type
Generic (ANDA)
FDA Application
ANDA090444On Market Since
4/16/2010
Pharmacological Classes
Price Statistics
The NADAC for IMIPRAMINE PAMOATE 100 MG CAP has been published 510 times since Nov 28, 2013, and over the history we have for it it has declined 41.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3963 per EA |
|---|---|
| All-time high | $8.9948 (Jun 15, 2016) |
| All-time low | $3.2982 (Apr 22, 2026) |
| 52-week high | $3.6892 |
| 52-week low | $3.2982 |
| Median price | $5.7687 |
| Average price | $5.8535 |
| Largest weekly change | +44.9% (Jan 22, 2014) |
| Weeks tracked | 510 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMIPRAMINE PAMOATE 100 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for IMIPRAMINE PAMOATE 100 MG CAP, manufactured by Lupin Pharmaceuticals Inc., is $3.3963 per EA (NDC 68180031506), effective Jun 24, 2026.
How has the price of IMIPRAMINE PAMOATE 100 MG CAP changed over time?
Over the history we have for it, the NADAC for IMIPRAMINE PAMOATE 100 MG CAP has declined 41.9%. It has been tracked across 510 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IMIPRAMINE PAMOATE 100 MG CAP?
Since Nov 28, 2013, the NADAC for IMIPRAMINE PAMOATE 100 MG CAP has ranged from a low of $3.2982 (Apr 22, 2026) to a high of $8.9948 (Jun 15, 2016), with a median of $5.7687 per EA.
Are there cheaper alternatives to IMIPRAMINE PAMOATE 100 MG CAP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as IMIPRAMINE PAMOATE 100 MG CAP, but none are currently priced below it.
Who manufactures IMIPRAMINE PAMOATE 100 MG CAP?
IMIPRAMINE PAMOATE 100 MG CAP (NDC 68180031506) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification